Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 29 of the 31 references it cites were found in a registry or an index.

Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis

Abstract

Background & aims The pathogenesis of nonalcoholic steatohepatitis (NASH) remains poorly understood. Although apoptosis is a common mechanism of liver injury, the extent and clinical significance of apoptosis in NASH has not been examined. Thus, the aims of this study were to quantify hepatocyte apoptosis in NASH, correlate it with disease severity, and identify possible mechanisms of apoptosis induction.Methods Hepatocyte apoptosis was assessed in NASH, simple steatosis, alcoholic hepatitis, and controls without liver disease using the TUNEL assay and immunohistochemistry for activated caspases 3 and 7. Liver specimens were also graded according to the magnitude of inflammation and fibrosis.Results TUNEL-positive cells were significantly increased in liver biopsy specimens from patients with NASH compared with simple steatosis and controls. Unexpectedly, TUNEL-positive cells were also greater in NASH vs. alcoholic hepatitis. Immunohistochemistry demonstrated active caspases 3 and 7 in NASH specimens, confirming the occurrence of apoptosis in this disease. A positive correlation was observed between hepatocyte apoptosis and hepatic fibrosis and inflammatory activity, respectively. The Fas receptor was strongly expressed in hepatocytes in liver specimens from NASH patients as compared with controls.Conclusions Hepatocyte apoptosis is significantly increased in patients with NASH and correlates with disease severity, suggesting that antiapoptotic therapy may be useful in this syndrome.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0016-5085(03)00907-7

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 31 references

Research works printed but not linked: 2

  1. Schaffner, 1986, Nonalcoholic fatty liver disease, Prog Liver Dis, 8, 283
  2. Valentino, 2002, First clinical trial of IDN-6556, Gastroenterology, 122, A622

Cited by

See all 1,085

Metadata

Authors
Feldstein, A. E., Canbay, A., Angulo, P., Taniai, M., Burgart, L. J., Lindor, K. D., & Gores, G. J.
Affiliations
Mayo Clinic (US)
Corresponding author
Gores, Gregory J
Venue
Gastroenterology
Publisher
Elsevier BV
Published
2003-08
Volume
125
Issue
2
Pages
437-443
ISSN
0016-5085 (ISSN-L)
OpenAlex
W2034188379
Cited by
1,085
References
31
Citations by year
2026: 20 · 2025: 32 · 2024: 43 · 2023: 42 · 2022: 47 · 2021: 57 · 2020: 55 · 2019: 41 · 2018: 57 · 2017: 55 · 2016: 49 · 2015: 52 · 2014: 60 · 2013: 48 · 2012: 43
FWCI
20.81
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Gastroenterology (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute of Diabetes and Digestive and Kidney Diseases (DK-41876)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
Keywords
nonalcoholic steatohepatitis, hepatocyte apoptosis, Fas, caspase-3, caspase-7, liver fibrosis, liver inflammation, disease severity, simple steatosis, alcoholic hepatitis, anti-apoptotic therapy
MeSH terms
Adult, Aged, Fatty Liver, Female, Humans, Immunohistochemistry, Male, Middle Aged, Apoptosis, fas Receptor, In Situ Nick-End Labeling, Hepatocytes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. https://app.cochat.ai/papers/10.1016/s0016-5085(03)00907-7
The paper
Feldstein, A. E., Canbay, A., Angulo, P., Taniai, M., Burgart, L. J., Lindor, K. D., & Gores, G. J. (2003). Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology. https://doi.org/10.1016/s0016-5085(03)00907-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.